Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

This page is no longer being updated and the information may be out of date.

ACMD Seminar: Optimal Control of Treatments for Retinitis Pigmentosa

Luis Melara
Department of Mathematics, Shippensburg University

Thursday, April 4, 3:00-4:00
Building 101, Lecture Room D
Gaithersburg

Thursday, April 4, 1:00-2:00
Building 1, Room 1107
Boulder

Host: Ryan Evans

Abstract:  Retinitis Pigmentosa (RP) is a degenerative eye disease affecting millions of people worldwide.  This presentation will discuss two treatments for RP:  Rod-derived Cone Viability Factor (RdCVF) and Mesencephalic-Astrocyte-derived-Neurotrophic Factor (MANF).  Both treatments rescue photoreceptors in the eye.  We model the RdCVF and MANF treatments by mathematically representing them as optimal control problems. We also present a preliminary optimal control model for mixed treatments of RP developed from previous work.  Numerical results are presented and discussed.

Bio: Luis Melara is an associate professor of Mathematics at Shippensburg University of Pennsylvania. He obtained his B.S. in Applied Mathematics from UCLA and a Ph.D. in Computational and Applied Mathematics from Rice University. He completed a National Research Council Postdoctoral Fellowship at the National Institute of Standards and Technology and is a past Fulbright-Nehru Scholar at the Indian Institute of Technology Bhubaneswar.  He is the current Editor-In-Chief for SIAM Undergraduate Research Online (SIURO). His current research interests are in mathematical biology and optimal control.

Note: Visitors from outside NIST must contact Cathy Graham; (301) 975-3800; at least 24 hours in advance.

Contacts

Created March 21, 2019, Updated May 27, 2026
Was this page helpful?